A two-cohort, phase II, cardiac safety study of pertuzumab, trastuzumab, and neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive, locally advanced, inflammatory, or early breast cancer Meeting Abstract


Authors: Swain, S. M.; Ewer, M. S.; Douthwaite, H.; Szado, T.; Waldron-Lynch, M.; Dang, C.
Abstract Title: A two-cohort, phase II, cardiac safety study of pertuzumab, trastuzumab, and neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive, locally advanced, inflammatory, or early breast cancer
Meeting Title: 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 75
Issue: 9 Suppl.
Meeting Dates: 2014 Dec 9-13
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2015-05-01
Language: English
ACCESSION: WOS:000356730200117
DOI: 10.1158/1538-7445.sabcs14-ot3-1-01
PROVIDER: wos
Notes: Meeting Abstract: OT3-1-01 -- 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium -- DEC 09-13, 2014 -- San Antonio, TX -- S -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Chau Dang
    271 Dang